Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Page values for "Irbesartan"

From Pharmacopedia
More actions

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringIrbesartan
brandStringAvapro
structureFile
classesList of String, delimiter: ,[[:Category:Angiotensin_receptor_blockers|Angiotensin receptor blocker (ARB)]] [[:Category:Antihypertensives|Antihypertensive]]
mechanismString'"`UNIQ--vote-0000083E-QINU`"' CYP2C9 substrate; no clinically active metabolites. The IDNT trial established renoprotection in diabetic nephropathy independent of BP lowering, contributing to the ARB class indication in T2DM with proteinuria'"`UNIQ--ref-0000083F-QINU`"'.
usesString'"`UNIQ--vote-00000840-QINU`"', '"`UNIQ--vote-00000841-QINU`"'
starting_doseString150 mg PO once daily; titrate to 300 mg if needed
preparationsString75, 150, 300 mg tablets
fda_maxString300 mg/d
pill_idText
routesList of String, delimiter: ,Oral
onsetStringBP effect within 1-2 weeks
durationString24 hours
halflifeString11-15 hours'"`UNIQ--ref-00000842-QINU`"'
bioavailabilityString60-80% (oral; not significantly affected by food)'"`UNIQ--ref-00000843-QINU`"'
pregnancyString'''Contraindicated in pregnancy''' (all trimesters); fetal renal injury, oligohydramnios, hypocalvaria, hypotension. Stop on detection'"`UNIQ--ref-00000844-QINU`"'
legalString[[USLegal:Prescription only|Rx-only]] in US